Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Zentalis Pharmaceuticals Inc (ZNTL)

Zentalis Pharmaceuticals Inc (ZNTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 309,673
  • Shares Outstanding, K 71,026
  • Annual Sales, $ 0 K
  • Annual Income, $ -292,190 K
  • 60-Month Beta 1.70
  • Price/Sales 7.64
  • Price/Cash Flow N/A
  • Price/Book 0.68
Trade ZNTL with:

Options Overview Details

View History
  • Implied Volatility 235.48% ( +72.41%)
  • Historical Volatility 91.24%
  • IV Percentile 96%
  • IV Rank 57.02%
  • IV High 402.91% on 08/15/24
  • IV Low 13.38% on 08/14/24
  • Put/Call Vol Ratio 0.01
  • Today's Volume 912
  • Volume Avg (30-Day) 592
  • Put/Call OI Ratio 0.26
  • Today's Open Interest 6,370
  • Open Int (30-Day) 2,304

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -0.91
  • Number of Estimates 8
  • High Estimate -0.77
  • Low Estimate -0.99
  • Prior Year -0.79
  • Growth Rate Est. (year over year) -15.19%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.95 +47.80%
on 09/06/24
5.44 -19.85%
on 09/16/24
+1.00 (+29.76%)
since 08/19/24
3-Month
2.83 +54.06%
on 08/14/24
5.70 -23.51%
on 06/20/24
+0.22 (+5.31%)
since 06/18/24
52-Week
2.83 +54.06%
on 08/14/24
23.12 -81.14%
on 09/20/23
-17.81 (-80.33%)
since 09/19/23

Most Recent Stories

More News
Why Shares of Zentalis Pharmaceuticals Dropped This Week

A rash of insider selling meant the stock gave back some of its gains from last week.

RHHBY : 39.4600 (-0.38%)
ZNTL : 4.36 (+4.81%)
Newman Ferrara LLP Announces Corporate Governance Investigations of Zentalis Pharmaceuticals, Inc. (ZNTL)

Newman Ferrara LLP announced today that the firm is conducting investigations on behalf of shareholders of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) (“Zentalis” or the “Company”). The investigations...

ZNTL : 4.36 (+4.81%)
Moore Kuehn, PLLC Encourages Investors of Zentalis Pharmaceuticals, Inc. to Contact Law Firm

/PRNewswire/ -- Moore Kuehn, PLLC, a securities law firm located on Wall Street, is investigating whether certain officers and directors of Zentalis...

ZNTL : 4.36 (+4.81%)
Zentalis Pharmaceuticals Reports Second Quarter 2022 Financial Results and Operational Update

Strengthened leadership team with the appointment of additional industry veterans, including CEO Dr. Kimberly Blackwell and Chairman Dave Johnson Received...

ZNTL : 4.36 (+4.81%)
Zentalis Pharmaceuticals to Participate in the Wedbush PacGrow Healthcare Conference

NEW YORK and SAN DIEGO, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company...

ZNTL : 4.36 (+4.81%)
Zentalis Pharmaceuticals, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

NEW YORK and SAN DIEGO, Aug. 01, 2022 (GLOBE NEWSWIRE) -- Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company...

ZNTL : 4.36 (+4.81%)
Zentalis Pharmaceuticals Appoints Andrea Paul as General Counsel and Corporate Secretary

NEW YORK and SAN DIEGO, June 27, 2022 (GLOBE NEWSWIRE) -- Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company...

ZNTL : 4.36 (+4.81%)
Zentalis Pharmaceuticals Appoints Andrea Paul as General Counsel and Corporate Secretary

NEW YORK and SAN DIEGO, June 27, 2022 (GLOBE NEWSWIRE) -- Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company...

ZNTL : 4.36 (+4.81%)
Zentalis Pharmaceuticals Promotes Cofounder Cam Gallagher to President

NEW YORK and SAN DIEGO, May 31, 2022 (GLOBE NEWSWIRE) -- Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company...

ZNTL : 4.36 (+4.81%)
Zentalis Pharmaceuticals Announces Closing of Underwritten Offering of Common Stock

NEW YORK and SAN DIEGO, May 18, 2022 (GLOBE NEWSWIRE) -- Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company...

ZNTL : 4.36 (+4.81%)

Business Summary

Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It is focused on discovering and developing small molecule therapeutics targeting cancers. The company's lead programs consist of ZN-c5, an oral selective estrogen receptor degrader for estrogen-receptor-positive, HER2-negative...

See More

Key Turning Points

3rd Resistance Point 4.73
2nd Resistance Point 4.59
1st Resistance Point 4.48
Last Price 4.36
1st Support Level 4.23
2nd Support Level 4.09
3rd Support Level 3.98

See More

52-Week High 23.12
Fibonacci 61.8% 15.37
Fibonacci 50% 12.98
Fibonacci 38.2% 10.58
Last Price 4.36
52-Week Low 2.83

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar